AB INBEV 58.980 € (-0,03 %) JENSEN-GROUP 64.400 € (-5,01 %) UCB 247.400 € (-0,48 %) KBC 102.950 € (-1,34 %) BREDERODE 101.000 € (-0,39 %) ARGENX SE 583.200 € (-0,85 %) COFINIMMO 81.250 € (0,00 %) FAGRON 21.500 € (-0,23 %) AGEAS 60.050 € (+1,26 %) D'IETEREN GROUP 157.500 € (-2,48 %) ACKERMANS V.HAAREN 262.200 € (+0,46 %) GBL 75.450 € (-0,46 %) MONTEA 64.800 € (-1,07 %) MELEXIS 50.900 € (0,00 %) NEXTENSA 43.400 € (+1,17 %) UMICORE 16.420 € (+4,32 %) PROXIMUS 7.000 € (+1,16 %) AEDIFICA 69.750 € (+0,36 %) VIOHALCO 12.620 € (-3,81 %) KBC ANCORA 69.300 € (-0,57 %) TITAN S.A. 45.600 € (+0,55 %) CIE BOIS SAUVAGE 314.000 € (-1,26 %) SYENSQO 47.190 € (+3,97 %) VASTNED 28.800 € (-0,35 %) AGFA-GEVAERT 0.463 € (-0,43 %) WDP 22.320 € (0,00 %) WERELDHAVE BELGIUM 53.800 € (0,00 %) AZELIS GROUP 7.945 € (+6,64 %) COLRUYT 34.100 € (+2,83 %) HOME INVEST BE. 18.380 € (-0,33 %) DEME GROUP 184.800 € (+0,43 %) BPOST 1.816 € (-0,22 %) CMB.TECH 10.980 € (+3,00 %) SOLVAC NOM(RETAIL) 64.400 € (-1,53 %) ONTEX GROUP 4.065 € (-1,81 %) VGP 84.800 € (-0,93 %) LOTUS BAKERIES 9 730.000 € (+1,04 %) RECTICEL 9.120 € (-2,36 %) SOLVAY 25.180 € (+0,88 %) TESSENDERLO 24.250 € (+0,83 %) EKOPAK 4.230 € (-2,98 %) IBA 13.480 € (-0,74 %) XIOR 26.400 € (-0,75 %) TUBIZE-FIN 209.000 € (-0,24 %) EVS BROADC.EQUIPM. 32.500 € (-0,76 %) CAMPINE 181.500 € (-1,36 %) INCLUSIO SA/NV 17.200 € (-0,29 %) ORANGE BELGIUM 20.200 € (0,00 %) UNIFIEDPOST GROUP 3.240 € (+1,25 %) BANQUP GROUP 3.240 € (+1,25 %) WHAT''S COOKING GP 141.500 € (+1,07 %) GIMV 43.750 € (0,00 %) RETAIL ESTATES 64.800 € (+0,78 %) NYXOAH 2.760 € (+1,85 %) SOFINA 214.400 € (-0,92 %) BIOTALYS 1.680 € (+1,20 %) FLUXYS BELGIUM D 20.800 € (+1,96 %) SEQUANA MEDICAL 0.508 € (-1,17 %) ONWARD MEDICAL 3.480 € (-1,14 %) CARE PROPERTY INV. 12.000 € (-0,17 %)
TELEPERFORMANCE 46.050 € (-6,99 %)
VALLOUREC 20.190 € (+2,88 %)
STMICROELECTRONICS 27.510 € (+1,89 %)
SOCIETE GENERALE 63.520 € (-0,50 %)
BNP PARIBAS ACT.A 82.940 € (-0,49 %)
AKZO NOBEL 48.940 € (+1,33 %)
SCHNEIDER ELECTRIC 241.800 € (-0,62 %)
ADYEN 888.500 € (+1,21 %)
LVMH 460.750 € (-1,25 %)
CARREFOUR 15.330 € (+2,17 %)
WINAMP GROUP 0.496 € (-6,42 %)
EXOR NV 63.500 € (-1,85 %)
ARCELORMITTAL SA 45.230 € (+2,31 %)
LEGRAND 135.500 € (+0,63 %)
SOITEC 50.700 € (-2,20 %)
BE SEMICONDUCTOR 184.100 € (+0,85 %)
TOTALENERGIES 77.210 € (+1,59 %)
SANOFI 77.770 € (+1,22 %)
AHOLD DEL 40.530 € (+1,17 %)
WOLTERS KLUWER 62.560 € (-1,97 %)
ORANGE 17.200 € (+1,42 %)
CREDIT AGRICOLE 16.105 € (-0,46 %)
SHELL PLC 39.925 € (+2,90 %)
CAPGEMINI 96.360 € (-1,91 %)
ESSILORLUXOTTICA 192.750 € (-0,16 %)
VINCI 127.350 € (+0,55 %)
ING GROEP N.V. 21.775 € (-1,43 %)
CATERING INTL SCES 13.300 € (+3,10 %)
TECHNIP ENERGIES 34.100 € (0,00 %)
EXOSENS 61.800 € (-2,06 %)
HEINEKEN HOLDING 60.800 € (-0,33 %)
DSM FIRMENICH AG 58.940 € (+1,41 %)
AXA 37.900 € (+0,08 %)
BUREAU VERITAS 26.000 € (0,00 %)
POUJOULAT 8.000 € (+2,04 %)
SAINT GOBAIN 70.420 € (-0,56 %)
BOLLORE 4.850 € (0,00 %)
VOPAK 45.620 € (+0,53 %)
SAFRAN 282.100 € (-1,81 %)
ABN AMRO BANK N.V. 26.760 € (-0,41 %)
EURONEXT 135.100 € (+1,66 %)
CRCAM NORM.SEINE 131.600 € (-2,79 %)
VIVENDI SE 1.689 € (-0,50 %)
PERNOD RICARD 62.900 € (-1,16 %)
RUBIS 33.280 € (+1,09 %)
SCOR SE 30.120 € (-0,07 %)
ARKEMA 54.300 € (+2,55 %)
NN GROUP 65.620 € (-0,36 %)
ASR NEDERLAND 58.200 € (+0,45 %)
ASML HOLDING 1 201.600 € (+2,23 %)
MOULINVEST 24.000 € (+1,69 %)
CORBION 18.340 € (+1,55 %)
TF1 6.920 € (0,00 %)
HIGH CO 3.490 € (-1,41 %)
UMG 15.465 € (-1,72 %)
BOURSE DIRECT 4.450 € (-1,98 %)
WORLDLINE DS 0.560 € (-19,56 %)
HEINEKEN 65.720 € (-0,03 %)
AALBERTS NV 30.360 € (-0,46 %)
OREGE 0.290 € (-2,68 %) News Réglementées
|
13/03/2026 09:00
Original-Research: MLP SE (von NuWays AG): BUYOriginal-Research: MLP SE - from NuWays AG Classification of NuWays AG to MLP SE
Core momentum points to guidance upside MLP’s Q4 results mark the end of a transition year. FY25 was shaped by weak performance fees and the real estate clean-up. The core business nevertheless continued to expand. As a result, 2026 starts from a cleaner base with the underlying growth profile becoming more visible again. Q4 group revenues increased 1% yoy to € 306m (eNuW: € 311m, also see p.2). Property & casualty remained the key growth driver, with revenues rising 11% yoy to € 46m, reflecting continued premium growth. While wealth revenues declined 1% yoy to € 138m, as expected, wealth sales excluding performance fees increased 5.8% yoy, confirming the positive trend. Q4 adj. group EBIT rose 26% yoy to € 36m (eNuW: € 34m), thanks to lower other operating expenses and reduced loan-loss provisions (together -8% yoy). The adjustment reflects a € -9.2m goodwill impairment following MLP’s decision to abandon new real estate development projects earlier in 2025. In 2026, we expect a 16% yoy adj. EBIT growth to € 112.5m, positioning ourselves above the guidance corridor (€ 100-110m). Revenues are expected to grow 6.6% to € 1,116m. Our estimates assume broadly stable performance fees of c. € 11m, reflecting limited visibility at this stage (eNuW). A broadly stable cost base, already visible in 2025, should support further operating leverage. We forecast a 0.8pp yoy improvement in the adj. EBIT margin (eNuW). Importantly, the Iran conflict has not translated into any visible change in client behaviour so far. Advisory activity and inflows remained stable despite the recent geopolitical tensions. This supports the view that client decisions are driven by long-term financial planning. The Q4 adj. EBIT growth rate of 26% also supports confidence in MLP’s mid-term outlook. A 14% adj. EBIT CAGR into 2028 looks well achievable (eNuW), even without improving performance fees. This growth should be supported by capital efficiency gains, with the dividend payout remaining at c. 50-70% (current yield c. 5%). In sum, MLP enters 2026 from a much cleaner base, with the drag from real estate now ringfenced and earnings quality becoming more transparent. The investment case increasingly centres on a resilient and structurally growing core franchise, led by recurring revenues (72% of total), improving capital efficiency and a controlled cost base. Against this backdrop, the current valuation still does not fully reflect the visibility of mid-term earnings growth, in our view. With adj. EBIT seen to compound at 14% into 2028, even without a recovery in performance fees, and with a dividend yield of c. 5%, the risk-reward remains attractive. Near-term news flow should also be supportive, as the 2026 guidance appears conservative in our view. BUY, PT € 12, based on Residual Income. You can download the research here: mlp-se-2026-03-13-longupdate-en-b5a14 For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2290868 13.03.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière